LUNG CANCER

Guardant Health’s comprehensive liquid biopsy test, Guardant360, provides quick and reliable treatment decisions for patients with advanced-stage cancer

The Guardant360 liquid biopsy test offered by Guardant Health AMEA has shown high agreement with tissue biopsies in detecting actionable mutations and this has helped to guide treatment decisions for patients with advanced-stage cancer.